NCT06397222
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC No drug interventions treatment 2 recruiting NCT02989922
A Study to Evaluate SHR-1210 in Subjects With Advanced HCC treatment 2 completed NCT03533920
Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT04967482
DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC No drug interventions treatment Not Available unknown_status NCT03138031
Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT05901194
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma treatment 1 / 2 not_yet_recruiting NCT05713994
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma Not Available Not Available recruiting NCT06133062
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT04522544
Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC treatment 2 recruiting NCT03379844
HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients No drug interventions treatment 2 completed NCT03881501
Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT05543304
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) No drug interventions Not Available Not Available enrolling_by_invitation NCT05057104
Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy No drug interventions Not Available Not Available not_yet_recruiting NCT04966195
Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis No drug interventions treatment Not Available completed NCT04997850
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma treatment 1 / 2 enrolling_by_invitation NCT05717738
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma Not Available Not Available recruiting NCT04599790
TACE Combined With Lenvatinib and Sintilimab for Advanced HCC treatment 2 completed NCT04511455
Cabozantinib for Patients With Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment treatment 2 active_not_recruiting NCT06561399
Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003) Not Available Not Available recruiting NCT05953337
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available recruiting NCT06535737
A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab treatment 2 not_yet_recruiting NCT06492395
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT No drug interventions treatment 3 not_yet_recruiting NCT06487663
TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors No drug interventions treatment Not Available recruiting NCT04224636
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab treatment 2 recruiting NCT06397235
DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC No drug interventions treatment 2 recruiting NCT06408753
Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT No drug interventions Not Available Not Available completed NCT04965454
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma other 2 recruiting NCT06375486
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. treatment 2 recruiting NCT05797870
Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2) treatment 2 recruiting NCT05911633
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available recruiting NCT06265883
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT No drug interventions Not Available Not Available completed NCT06187961
Combined HAIC, Lenvatinib and Cadonilimab as Conversion Therapy for Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT05031949
Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma treatment 1 recruiting NCT05497453
A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene treatment 1 / 2 recruiting NCT04926376
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC No drug interventions treatment Not Available completed NCT06040177
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus treatment 1 / 2 recruiting NCT05985798
Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC No drug interventions treatment 3 recruiting NCT05992220
Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion treatment 2 recruiting NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT02967887
Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC treatment 2 unknown_status NCT03277716
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge No drug interventions treatment Not Available unknown_status NCT03283956
Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan No drug interventions Not Available Not Available unknown_status NCT03563170
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine treatment 1 / 2 withdrawn NCT03564405
Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT03652467
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma treatment 1 recruiting NCT03807947
Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT03864211
Thermal Ablation Followed by Immunotherapy for HCC treatment 1 / 2 active_not_recruiting NCT04273100
PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC treatment 2 unknown_status NCT04592029
TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC treatment 1 active_not_recruiting NCT04599777
TACE Combined With Sorafenib and Tislelizumab for Advanced HCC treatment 2 completed NCT04718909
Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC treatment 2 active_not_recruiting NCT04996914
Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma No drug interventions treatment Not Available not_yet_recruiting NCT05114148
Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05390112
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization No drug interventions Not Available Not Available recruiting NCT05530785
Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT treatment Not Available recruiting NCT05608213
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC treatment 3 recruiting NCT05638438
Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study No drug interventions Not Available Not Available not_yet_recruiting NCT04967495
TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT No drug interventions treatment Not Available recruiting NCT05608200
Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC treatment 3 recruiting NCT01891539
Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT01835223
Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery treatment 1 / 2 completed NCT05609448
MRI-guided Holmium-166 Radioembolization No drug interventions treatment Not Available enrolling_by_invitation NCT03044587
Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer treatment 2 active_not_recruiting